Fourteenth Annual
Connoisseur’s Dinner

Fourteenth Annual Connoisseur’s Dinner

May 6, 2020

6:30 – 10:00pm

 

Sotheby’s
1334 York Avenue at 72nd Street
New York, NY

Online ticket sales will open in January 2020. For advanced reservations and more information, contact rsvp@alzdiscovery.org or 212-901-7990

Tenth Annual Great Ladies Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Tenth Annual
Great Ladies Luncheon

Tenth Annual Great Ladies Luncheon

Wednesday, April 29, 2020

10:30am-2:00pm

 

The Ritz-Carlton
1150 22nd Street NW
Washington DC

Online ticket sales will open in January 2020. For advanced reservations and more information, contact rsvp@alzdiscovery.org or 212-901-7990

Third Annual Memories Matter | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Third Annual
Memories Matter

Third Annual Memories Matter

Wednesday, March 25, 2020

6:30-10:30pm

 

Pier 60, Chelsea Piers
New York, NY

Online ticket sales will open in January 2020. For advanced reservations and more information, contact rsvp@alzdiscovery.org or 212-901-7990

Third Annual Hope on the Horizon Palm Beach Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Third Annual
Hope on the Horizon Palm Beach Luncheon

Third Annual Hope on the Horizon Palm Beach Luncheon

Wednesday, March 11, 2020

Noon – 2:00pm

 

The Beach Club
755 North County Road
Palm Beach, FL

Online ticket sales will open in January 2020. For advanced reservations and more information, contact rsvp@alzdiscovery.org or 212-901-7990

2019 TCS New York City Marathon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

2019 TCS New York City Marathon

2019 TCS New York City Marathon

November 3, 2019

 


New York, NY

The ADDF is proud to be an official charity partner for the 2019 TCS New York City Marathon. Donations to our team directly support research into new treatments for this devastating disease. In 2018, our team of runners from all over the world raised over $110,000. And 100% of the funds they raised went directly to Alzheimer's research.

Our 2019 team is currently full. To be placed on our waiting list or to receive more information, please contact Christine Scerra at 212.901.8011 or cscerra@alzdiscovery.org.

Tenth Annual Fall Symposium & Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Tenth Annual
Fall Symposium & Luncheon

Tenth Annual Fall Symposium & Luncheon

November 1, 2019

10:30 am | Symposium

12:00 pm | Luncheon

 

The Pierre
2 East 61st Street
New York, NY

Please join us for the Tenth Annual Fall Symposium & Luncheon Hope on the Horizon. This event consists of a morning symposium with leading Alzheimer's researchers and is followed by a luncheon to present the Charles Evans Award.

We are thrilled to present the Charles Evans Award to Pamela J. Newman, President and CEO of PJN Strategies LLC.  Pamela will be honored for her deep commitment and tireless efforts on behalf of our mission.

The morning symposium will be moderated by Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF.  The focus of the discussion is repurposing drugs for Alzheimer’s disease.

All proceeds from the event support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related diseases.

For more information, contact rsvp@alzdiscovery.org.

LEADERSHIP


Honorary Chairs

Bonnie Pfeifer Evans
Alice Shure

 

Host Committee

Steve Acunto
Carol Seabrook Boulanger
Gerry Brown
John Catsimatidis
Anla Cheng
Mitchell D. Eichen
Phebe Farrow Port
Jennifer Fearon
Diane Finnerty
Stan Galanski
Susan Gutfreund
Charlene Haroche
Christopher Johnson

Event Co-Chairs

Sharon T. Sager, CIMA
David R. Weinreb

 

Host Committee, contd.

Elizabeth R. Kabler
Alice Kane
Mitchell Kaneff
Amie and Louis Kreisberg
Gary M. Lauder
Bonnie Englebardt Lautenberg
Julie Medler
Justin Meltzer
Istvan Nadas
Tom Scanlan
Hadley and John Scully
Stephen Toma
Lori Kanter Tritsch and William P. Lauder

20th International Conference on Alzheimer’s Drug Discovery | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

20th International
Conference on Alzheimer's Drug Discovery

20th International Conference on Alzheimer’s Drug Discovery

September 16-17, 2019

 

Hyatt Regency
2 Exchange Place
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer's disease and related dementias. The ADDF's funded investigators and leading scientists in the field present their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

Read about last year's conference.

SCHOLARSHIP DEADLINE: JULY 26, 2019

Graduate students and postdoctoral fellows are invited to apply for a Young Investigator Scholarship to attend the conference for free and present a poster of their research. Three recipients will also have the opportunity to give an oral presentation to conference attendees.

EARLY BIRD DEADLINE: AUGUST 16, 2019

Register early and save up to $150 on conference rates.


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Thirteenth Annual Connoisseur’s Dinner | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Thirteenth Annual
Connoisseur's Dinner

Thirteenth Annual Connoisseur’s Dinner

May 30, 2019

6:30 pm | Cocktails

7:30 pm | Dinner

Black Tie

 

Sotheby's
1334 York Avenue
New York, NY

The Thirteenth Annual Connoisseur's Dinner celebrated the one-year anniversary of Diagnostics Accelerator, the ADDF's program to fund innovative Alzheimer's biomarkers and diagnostic technologies. The gala recognized the program's funding partners Bill Gates, Leonard A. Lauder, the Dolby family, the Charles and Helen Schwab Foundation, Jeff and Mackenzie Bezos, and others.

The event featured a preview of Sotheby's upcoming auctions, wine pairings presented by Sotheby's Wine, and our lively "Fund a Scientist" Auction, which supports the ADDF's promising Alzheimer's research.

LEADERSHIP


Executive Chairs

  • Jo Carole and Ronald S. Lauder
  • Judy and Leonard A. Lauder
  • Liz and Randal Sandler

Founding Chair

  • Nancy Corzine
Ninth Annual Great Ladies Luncheon & Fashion Show | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Ninth Annual
Great Ladies Luncheon & Fashion Show

Ninth Annual Great Ladies Luncheon & Fashion Show

May 1, 2019

10:30 am–2:00 pm

 

The Ritz-Carlton
1150 22nd Street NW
Washington, DC

The Alzheimer's Drug Discovery Foundation with Neiman Marcus Tysons Galleria and Mazza Gallerie presented the Ninth Annual Great Ladies Luncheon & Fashion Show featuring the Carolina Herrera Spring and Fall 2019 Collection.

Hosted by sports broadcaster Lindsay Czarniak, the event honored T.J. Oshie of the Washington Capitals, and Michela Gallagher, PhD, Founder and CEO of AgeneBio, Inc.

The Symposium to Conquer Alzheimer's preceded the luncheon and feature a panel of leading scientists led by Howard Fillit, MD.

Marilyn S. Albert, PhD, Johns Hopkins School of Medicine
Richard S. Isaacson, MD, Weill Cornell Memory Disorders Program
Eric Siemers, MD, Siemers Integration LLC

LEADERSHIP


Founding Executive Chairs

  • Elise and Marc Lefkowitz
  • Leonard A. Lauder
  • Ronald S. Lauder
Clinical Trial Considerations in Neurodegenerative Disease Webinar | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Webinar
Clinical Trial Considerations in Neurodegenerative Disease

Clinical Trial Considerations in Neurodegenerative Disease Webinar

April 10, 2019

4:00 pm ET

1:00 pm PT

 

Online

Running clinical trials for neurodegenerative disease can be challenging, due to the complexity of studies, rapidly evolving knowledge of disease areas, regulatory considerations, obstacles facing patient recruitment, and difficulties in patient retention.

Drawing from her extensive experience in managing clinical trials in Alzheimer's disease, Parkinson's disease, Huntington's disease, and multiple other neurological disorders, Dr. Tina Soulis of Neuroscience Trials Australia will share best practices and helpful tips for moving clinical stage research forward.

You'll Learn:

  • Unique considerations for running clinical trials for neurodegeneration-related diseases, including choosing biomarkers, study design, and data management
  • Advantages of running clinical trials in Australia
  • How to optimize patient recruitment and retention specifically for neurodegenerative diseases

About the Speaker

Tina Soulis, PhD, is the CEO of Neuroscience Trials Australia. She is considered an industry thought leader and Australian international advocate for clinical trials. She contributes to and is a pivotal member on many Australian and international clinical trial advocacy, policy and neurology focused leadership groups.

Over the past 7 years, Soulis has built up Neuroscience Trials Australia, a leading global specialised brand making Australia a destination for many overseas companies wanting to undertake neurology focused clinical research. This contract research organisation (CRO) is globally unique and offers clients access to clinical trial sites, expertise and capabilities required to complete clinical development at global standard.


 

Brought to you by ADDF ACCESS, a program of the ADDF and Science Exchange, as part of our commitment to connect ADDF researchers with technologies that can help accelerate breakthrough discoveries.

Second Annual Memories Matter | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Second Annual
Memories Matter

Second Annual Memories Matter

April 9, 2019

6:30–10:30 pm

 

Pier 60, Chelsea Piers
New York, NY

The Second Annual Memories Matter event featured cocktails and dinner, an informative program, a silent auction, and special guests Ashley Campbell and Weather Anchor for NBC4 New York Dave Price. Ashley Campbell joined us for a memorable performance honoring her father, Glen Campbell. Desserts and décor were provided by the remarkable Larry Scott Events.

All proceeds from Memories Matter support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related diseases.

LEADERSHIP


Founding Chairs

  • Stephanie and Ian Ginsberg
  • Wendy Wilshin and Ronald Dickerman

Honorary Chairs

  • Leonard A. Lauder
  • Ronald S. Lauder

Co-Chairs

  • Hope and Marc Altheim
  • Anne and Andrew Diamond
  • Cindy and Glen Edelman
  • Elizabeth and Paul Greenbaum
  • Sheri and Seth Leist
  • Andrea and Jeffrey Lomasky
  • Roni and Charlie McGuffog
  • Karen and Marc Spector
  • Cindy and Laurence Tell

Host Committee

  • Michelle Romanoff Cohen
  • Iris and Jay Dankner
  • Jacalyn & Joel Florin
  • Terri Kahan
  • Carla and Rob Karen
  • Lori and Jimmy Krantz
  • Amelia and Steven Paston
  • Lisa Ritter-Kahn
  • Jamie Seidner and Jonathan Rubin
13th Annual Drug Discovery for Neurodegeneration Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

13th Annual
Drug Discovery for Neurodegeneration Conference

13th Annual Drug Discovery for Neurodegeneration Conference

March 17-19, 2019

 

Renaissance Long Beach Hotel
111 East Ocean Boulevard
Long Beach, CA

An Educational Course on Translating Research into Drugs

This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The programs will also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to neurodegenerative diseases.


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Second Annual Hope on the Horizon Palm Beach Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Second Annual
Hope on the Horizon Palm Beach Luncheon

Second Annual Hope on the Horizon Palm Beach Luncheon

March 4, 2019

11:30 am-2:00 pm

 

The Colony Hotel
155 Hammon Avenue
Palm Beach, FL

The Second Annual Hope on the Horizon Palm Beach Luncheon honored Marcia Gay Harden, Academy and Tony Award winner, author, and activist. The afternoon featured Howard Fillit, MD, ADDF Founding Executive Director and Chief Science Officer in conversation with ADDF-funded scientist Dr. Michela Gallagher discussing biomarkers to accelerate drug development for Alzheimer's disease.

All proceeds support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related dementias.

For more information, please contact rsvp@alzdiscovery.org.

LEADERSHIP


Executive Chairs

  • Leonard A. Lauder
  • Ronald S. Lauder

Co-Chairs

  • Nancy Goodes
  • Jan Willinger
Sip & Shop at J.McLaughlin in Palm Beach | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughlin in Palm Beach

Sip & Shop at J.McLaughlin in Palm Beach

January 23, 2019

2:00-6:00 pm

 

J.McLaughlin
225 Worth Avenue
Palm Beach, FL

Join hosts Nancy Goodes and Jan Willinger at classic American clothier J.McLaughlin's Palm Beach location for a fun afternoon of light bites, drinks, and shopping.

J.McLaughlin will donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer's and related dementias.


Stay Updated on Where the ADDF Will Be Next

Sign up today for emails about our upcoming events.

Predictive Disease Models for CNS Drug Development Webinar | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Webinar
Predictive Disease Models for CNS Drug Development

Predictive Disease Models for CNS Drug Development Webinar

November 14, 2018

11:00 am ET

8:00 am PT / 5:00 pm UTC

 

30 Minutes &
10 Minutes Q&A

This webinar presented by QPS Neuropharmacology discussed validated transgenic and non-transgenic in vitro and in vivo models covering most targets of Alzheimer's, Parkinson's, Huntington's, and other neurodegenerative diseases.

Topics

  • When to use animal models in your drug discovery program
  • How to choose the most appropriate animal model for your therapeutic or mechanism of action
  • How to design the most efficient "first-pass" proof-of-concept study
  • Best practices for submitting compounds and sample requirements for a successful study

About the Speaker

Birgit Hutter-Paier, PhD, is the Director of Neuropharmacology at QPS Austria. She has extensive experience in life science research and development, covering drug discovery and project management and directing multiple diverse, concurrent projects from ranging from early preclinical stages to pharmacology. She has created state-of-the-art labs as well as a behavioral pharmacology testing facility. Dr. Hutter-Paier established and managed the preclinical research group, with whom she develops transgenic and non-transgenic mouse models, mainly in Alzheimer's and Parkinson's disease research.


Brought to you by ADDF ACCESS, a program of the ADDF and Science Exchange, as part of our commitment to connect ADDF researchers with technologies that can help accelerate breakthrough discoveries.

ADDF to Exhibit at the Society for Neuroscience Annual Meeting 2018 | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF Exhibiting at
The Society for Neuroscience Annual Meeting

ADDF to Exhibit at the Society for Neuroscience Annual Meeting 2018

November 3-7

 

San Diego Convention Center
111 West Harbor Drive
San Diego, CA

Come visit the ADDF at booth 4232 at the 48th Annual SfN Meeting! Meet with our leading team of neuroscientists to talk about your projects, learn about our educational opportunities, and get information on the ADDF ACCESS program.


Get Updates on Where the ADDF will be Next

Sign up to receive news by email.

2018 TCS New York City Marathon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

2018 TCS New York City Marathon

2018 TCS New York City Marathon

November 4, 2018

 


New York, NY

The ADDF is proud to be an official charity partner for the 2018 TCS New York City Marathon. Donations to our team, Runners for Alzheimer's Research, directly support research into new treatments for this devastating disease. In 2017, our team of runners from all over the world raised over $100,000. And 100% of the funds they raised went directly to Alzheimer's research.

What All Team Members Receive

  • Guaranteed entry into the 2018 TCS New York City Marathon
  • Personalized 12-, 16-, or 20-week online training plan based on your fitness level and running experience
  • Fundraising tips and support, including a personal fundraising page and one-on-one staff support to help you meet your goals
  • Custom ADDF tech shirt for race day
  • Opportunities to join team runs and events throughout the year
  • Pre-race team dinner

For more information, contact Christine Scerra for more information at 212.901.8011 or cscerra@alzdiscovery.org.

Ninth Annual Fall Symposium & Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Ninth Annual
Fall Symposium & Luncheon

Ninth Annual Fall Symposium & Luncheon

November 2, 2018

10:30 am | Symposium

12:00 pm | Luncheon

 

The Pierre
2 East 61st Street
New York, NY

The Ninth Annual Fall Symposium & Luncheon "Hope on the Horizon" comprised a morning symposium with leading Alzheimer's researchers and a luncheon to present the Charles Evans Award. This year we honored David R. Weinreb, Chief Executive Officer of The Howard Hughes Corporation.

The event began with a morning symposium "Biomarkers to Accelerate Drug Development for Alzheimer's Disease," moderated by Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF. Panelists include:

  • Richard S. Isaacson, MD, Director, Alzheimer's Prevention Clinic, Weill Cornell Memory Disorders Program
  • Michelle M. Mielke, PhD, Professor, Departments of Health Sciences Research & Neurology, Mayo Clinic
  • Mark A. Mintun, MD, Vice President of Neuroscience, Eli Lilly & Co.

All proceeds from "Hope on the Horizon" support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related diseases.

EVENT SPONSORS


LEADERSHIP


EVENT LEADERSHIP SUPPORT

  • Caryn Clayman
  • Colliers International NY LLC
  • Joyce B. Cowin
  • Fox Family Foundation
  • Nancy and Melvin R. Goodes
  • Jo Carole and Ronald S. Lauder
  • Judy and Leonard A. Lauder
  • Samuel I. Newhouse Foundation, Inc.
  • Liz and Randal Sandler
  • The Sheldon H. Solow Foundation
  • Laura and Stephen Toma
  • Wendy Wilshin and Ronald Dickerman

Host Committee

  • William A. Ackman,
  •   Pershing Square Capital
  •   Management, L.P.
  • Iris Apfel
  • Carol Seabrook Boulanger
  • Charlie Cangro
  • James Carrier
  • Carole Cooper and Richard Leibner
  • Adam Eisenberg
  •   Ibex Investors
  • Bonnie Pfeifer Evans
  • Olivia Tournay Flatto, PhD
  • Susan Gutfreund
  • Karlyn and Grant Herlitz
  • Richard L. Hoffman
  • Kiera and Chris Johnson
  • Yue Sai Kan
  • Deborah and Peter Krulewitch
  • Karolina Kurkova
  • Laura and Gary Lauder
  • Bonnie Englebardt Lautenberg
  • Larry Leeds
  • Carol and John Levy
  • Pamela Liebman,
  •   The Corcoran Group
  • Serena and John Liew
  • Philip Lovett
  • Susan and Tom Lowder
  • Julie Medler
  • Michael Meldman,
  •   Discovery Land Company
  • Justin Meltzer
  • Robin Meltzer
  • Pamela J. Newman
  • Sarah Jessica Parker
  • Elaine and Trevor Pearlman
  • Denise Rich
  • Sharon T. Sager and
  •   J. Loring Swasey
  • Tom Scanlan
  • Saul A. Scherl
  • June and Paul Schorr
  • Hadley and John Scully
  • Patrick Shaw,
  •   Ehrenkranz Partners
  • Alice Shure
  • Klara and Larry A. Silverstein
  • Jeff Sodine
  • Mary Ann Tighe, CBRE
  • Tanya and David Tisch
  • Barbara and Donald Tober
  • Lori Kanter Tratsch and
  •   William P. Lauder
  • Vanessa Williams
  • Paula Zahn
143rd Annual Meeting of the American Neurological Association | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF Exhibiting at the
143rd Annual Meeting of the American Neurological Association

143rd Annual Meeting of the American Neurological Association

October 21-23, 2018

 

Hyatt Regency Hotel
265 Peachtree Street NE
Atlanta, GA

ANA2018, the American Neurological Association's 143rd Annual Meeting, offers exceptional education, career development for all levels of academic neurology and networking opportunities with leaders in the field. Scientific symposia cover a broad spectrum of subspecialties. Poster sessions are packed with the latest emerging neuroscience, and interactive lunch workshops take breakout sessions to the next level. Visit the ADDF exhibit booth to learn about our funding opportunities, educational resources, and CognitiveVitality.org, our website dedicated to helping people make informed decisions about brain health.


Get Updates on Where the ADDF will be Next

Sign up to receive news by email.

Sip & Shop at J.McLaughlin | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughlin

Sip & Shop at J.McLaughlin

September 20, 2018

6:00 - 8:00 pm

 

J.McLaughlin
1004 Lexington Avenue
New York, NY

Shop for a cause! Join us for a fun evening of light bites and drinks while you shop the Fall 2018 Collection from classic American clothier J.McLaughlin at its 1004 Lexington Avenue location.

J.McLaughlin will generously donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer's and related dementias.


Get the Latest on Our Upcoming Events

Sign up today for emails about the ADDF's events.

19th International Conference on Alzheimer’s Drug Discovery | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

19th International
Conference on Alzheimer's Drug Discovery

19th International Conference on Alzheimer’s Drug Discovery

September 17-18, 2018

 

Hyatt Regency
2 Exchange Place
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer's disease and related dementias. The ADDF's funded investigators and leading scientists in the field present their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

SESSIONS

  1. Gene Therapy and Alternative Modalities for Neurodegenerative Diseases
  2. Novel Small Molecule Approaches to Dementia
  3. Biomarkers
  4. Clinical Trials

Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Alzheimer’s Association International Conference 2018 | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF Exhibiting at the
Alzheimer's Association International Conference 2018

Alzheimer’s Association International Conference 2018

July 22-26, 2018

 

McCormick Place
2301 South King Drive
Chicago, IL

The Alzheimer's Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world's leading basic science and clinical researchers, next generation investigators, clinicians, and the care research community to share research discoveries that will lead to methods of prevention and treatment, and improvements in diagnosis for Alzheimer's disease.

Visit booth 529 to learn about the ADDF's ACCESS program, educational conferences, and funding opportunities.

Managing Neuropsychiatric Symptoms in Neurodegenerative Disease | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Symposium
Managing Neuropsychiatric Symptoms in Neurodegenerative Disease

Managing Neuropsychiatric Symptoms in Neurodegenerative Disease

June 14, 2018

 

The New York Academy of Sciences, 7 World Trade Center, Floor 40
New York, NY

Neuropsychiatric symptoms such as agitation, aggression and psychosis are frequently found in patients with neurodegenerative disorders. These symptoms increase the already significant burden of neurodegenerative diseases and complicate diagnosis and disease management, yet effective diagnostics and treatments are lacking.

Towards the goal of reducing this burden, this symposium will review state-of-the-art methods in the diagnosis and behavioral and pharmaceutical management of neuropsychiatric symptoms across a spectrum of neurodegenerative diseases. Speakers, including the ADDF's Chief Science Officer Howard Fillit, MD, will address the challenges of defining neuropsychiatric symptoms in the context of neurodegenerative diseases, present findings regarding emerging diagnostic biomarkers and novel therapies, and discuss current estimates of associated societal and economic costs. A closing panel discussion will identify strategies to reduce these costs for patients, caregivers, and society.

This symposium is presented by The Brain and Behavior Discussion Group and co-organized by the Alzheimer's Drug Discovery Foundation, Mount Sinai Medical Center, and the New York Academy of Sciences.

Twelfth Annual Connoisseur’s Dinner | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Twelfth Annual
Connoisseur's Dinner

Twelfth Annual Connoisseur’s Dinner

May 3, 2018

6:00 pm | Cocktails

7:30 pm | Dinner

Black Tie

 

Sotheby's
1334 York Avenue
New York, NY

The ADDF's annual gala presented the Chairman's Award to Fabrizio Freda, President and CEO, The Estée Lauder Companies, who accepted on behalf of The Estée Lauder Companies. This award was established by our Co-Chairmen Leonard Lauder and Ronald Lauder to recognize a prominent leader who is advancing our efforts to prevent, treat, and ultimately cure Alzheimer's disease.

The event also featured a selection of Sotheby's Spring Sales, delicious wine pairings presented by Sotheby's Wine, and our lively "Fund a Scientist" Auction, giving guests a special opportunity to support the ADDF's promising Alzheimer's research.

The evening was hosted by award-winning journalist Paula Zahn.

EVENT SPONSORS


  • Estee Lauder Companies
  • A.T. Kearney
  • BlackRock
  • EY
  • Firmentich
  • Gardiner & Theobald
  • Gensler
  • Givaudan
  • Hearst Magazines
  • Intercos
  • International Flavors and Fragrances
  • J.P. Morgan
  • The Kaneff Foundation
  • Deloitte
  • Macy's
  • Nucor Construction
  • Sotheby's
  • Tishman Speyer
  • Continental Grain Company

LEADERSHIP


Executive Chair

  • The Estée Lauder Companies Inc.
  • Judy and Leonard A. Lauder
  • Jo Carole and Ronald S. Lauder
  • Liz and Randal Sandler

Founding Chair

  • Nancy Corzine

Co-Chairs

  • Nancy and Melvin R. Goodes
  • The Margaret and Daniel Loeb – Third Point Foundation
  • Anne and Chris Reyes
  • Samuel I. Newhouse Foundation
  • Lori Kanter Tritsch and William P. Lauder

Vice Chairs

  • A.T. Kearney, Inc.
  • BlackRock
  • Carol S. Boulanger
  • Rose Marie Bravo and William Jackey
  • Bonnie Englebardt Lautenberg
  • The Estée Lauder Companies, Board of Directors
  • EY
  • Firmenich
  • Mary-Ann and Fabrizio Freda
  • Gardiner and Theobald, Inc.
  • Gensler
  • Givaudan
  • Hearst Magazines
  • Intercos
  • International Flavors and Fragrances Inc.
  • J.P. Morgan
  • The Kaneff Foundation
  • Jennifer Lacks Kaplan, Deloitte
  • Laura and Gary Lauder
  • Macy's and Bloomingdales
  • Nancy and Howard Marks
  • Nucor Construction Corp.
  • Sharon and Bob Prince
  • Sotheby's
  • Ann and Andrew Tisch
  • Tishman Speyer Properties, LP
  • Carol and Michael Weisman
  • Paula Zahn
Eighth Annual Great Ladies Luncheon & Fashion Show | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Eighth Annual
Great Ladies Luncheon & Fashion Show

Eighth Annual Great Ladies Luncheon & Fashion Show

April 18, 2018

10:30 am | Symposium

12:00 pm | Luncheon

 

The Ritz-Carlton
1150 22nd Street NW
Washington, DC

The Alzheimer's Drug Discovery Foundation and Neiman Marcus Mazza Gallerie presented the Eighth Annual Great Ladies Luncheon & Fashion Show, hosted by CNN Lead Political Anchor Wolf Blitzer. At this year's luncheon, we were thrilled to present the Great Ladies Award to Neiman Marcus Group, which was accepted by Karen Katz, Board member and former President and CEO.

Neiman Marcus has been an exceptional partner of this event for the past three years, continuously supporting the ADDF and our mission to cure Alzheimer's. The afternoon also featured a special runway show by our fashion partner Etro.

The luncheon was preceded by the Symposium to Conquer Alzheimer's, featuring a panel of leading scientists led by Howard Fillit, MD.

Symposium Panelists

Susan Catalano, PhD, Cognition Therapeutics
Yuko Hara, PhD, Alzheimer's Drug Discovery Foundation
Eugenia Trushina, PhD, Mayo Clinic

The Great Ladies Luncheon is generously underwritten by Elise Lefkowitz.

For more information, please contact rsvp@alzdiscovery.org.

EVENT SPONSORS


  • Estee Lauder Companies
  • Etro
  • Eli Lilly
  • Neiman Marcus

LEADERSHIP


Founding Executive Chairs

  • Elise and Marc Lefkowitz
  • Leonard A. Lauder
  • Ronald S. Lauder

Honorary Chairs

  • Andrea Mitchell
  • Ambassador of Italy and Mrs. Armando Varricchio

Gentlemen's Benefit Committee Chair

  • Marc D. Lefkowitz

Gentlemen's Benefit Committee

Jeffery Ashin
Leonard Banner
Philip Bobrow, MD
Davis Camalier
John Cecchi
Shane Crowley
David Deckelbaum
Marc Duber
Amb. Paul D. Frazer
Brian Friedman
Jim Glassman
Israel Kogan, MD
Michael Landow

Matthew Lefkowitz
Adam Mahr
Bennett R. Marshall
John J. Mason
William Miller
Thomas Pheasant
Hon. Edward A. Powell
Tony Powell
Bruce Rashbaum
Sonny Small
Andre Spearman
Fabio Trabocchi

Ladies Benefit Committee Co-Chairs

  • Shelley Banks
  • Nancy Taylor Bubes
  • Connie Carter
  • Marcella Cohen
  • Dana Landow
  • Kelly Ripken
  • Patricia Bennett Sagon

Ladies Benefit Committee

Pennie Abramson
Lise Adkins
Lauren Mason Ali
Tina S. Alster, MD
Amy Baier
Lisa B. Beek
Grace Bender
Tracy Bernstein
Wilma Bernstein
Admiral Susan Blumenthal, MD
Faith Bobrow
Evelyn T. Brandt
Jill Brigati
Lynda Camalier
Lynda Carter
Sharon Collins Casey
Kristin Rae Cecchi
Rose Cohen
Meryl Comer
Lizette Corro
Charlie Lefkowitz Crowley
Alexandra de Borchgrave
Debbie Dingell
Martha Dippell
Amy Donnelly
Nancy Duber
Liz Dubin
Deborah L. Epstein
Samia Farouki
Ann Free
Debra Friedmann
Elizabeth W. Galvin
Beth Glassman
Nancy Goodes
Sarah G. Gund
Ann Hand

Maddie Harris
Dena Henry
Raeanne Hytone
Cindy Jones
Katy Kamen
Mary Ann Kibarian
Phyllis L. Kim
Diana Kogan
Willee Lewis
Kristin Lund
Marlene A. Malek
Dobra Marshall
JoAnn Mason
Lisa Mathers
Barbara McInerney
Paige McKenzie
Elaine Miller
Laurie Monahan
Melanie Nussdorf
Mary Ourisman
Ginger Pickle
Diane Powell
Jaclyn Mason Randall
Genevieve McSweeney Ryan
Marilou Sanford
Deborah Sigmund
Bobbi Smith
Bonnie Staffier
Mariella Trager
Liz Underhill
Toni Verstandig
Lorraine Wallace
Anne Hatfield Weir
Dr. Tina B. West
Cathy Merrill Williams
Delores Wolf

 
Memories Matter | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Memories Matter

Memories Matter

April 10, 2018

6:30–10:30 pm

Business Attire

 

Pier 60, Chelsea Piers
New York, NY

Guests discussed the latest advances in Alzheimer's research with ADDF scientists; took in a performance by special musical guest The Nancy Atlas Project featuring Randi Fishenfeld on violin; enjoyed a seated dinner; experienced desserts and decor by the talented Larry Scott Events; and bid with the best at a silent auction.

Memories Matter was generously underwritten by Stephanie and Ian Ginsberg, and Wendy Wilshin and Ronald Dickerman.

For more information, please contact rsvp@alzdiscovery.org.

LEADERSHIP


Founding Chairs

  • Stephanie and Ian Ginsberg
  • Wendy Wilshin and Ronald Dickerman

Honorary Chairs

  • Jo Carole and Ronald S. Lauder
  • Judy and Leonard A. Lauder

Co-Chairs

  • Hope and Marc Altheim
  • Cindy and Glen Edelman
  • Elizabeth and Paul Greenbaum
  • Sheri and Seth Leist
  • Andrea and Jeffrey Lomasky
  • Roni and Charles McGuffog
  • Karen and Marc Spector
  • Cindy and Laurence Tell

Entertainment Chairs

  • Cori and Sandy Goldfarb

Host Committee

  • Jill and Michael Berman
  • Tracey and Mark Bilski
  • Karen and Len Breslow
  • Anne and Andrew Diamond
  • Kiera and Christopher Johnson
  • Lisa Ritter Kahn
  • Carla and Rob Karen
  • Lori and Jimmy Krantz
  • Julie Levine and Dean Johnson
  • Elyssa and Mitch Margolis
  • Candace and Jeff Moskowitz
  • Amelia and Steven Paston
  • Lori and John Reinsberg
  • Shari and Mel Stark
  • Amy Tannenbaum
  • Dana and Craig Vogel
  • Jillian Winoker
Aging in America 2018 Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF Exhibiting at the
Aging in America 2018 Conference

Aging in America 2018 Conference

March 26-29, 2018

 

Hilton San Francisco Union Square
333 O'Farrell Street
San Francisco, CA

The American Society on Aging's Aging in America Conference is the nation's largest and most dynamic multidisciplinary event known for its comprehensive view of the issues, challenges, and opportunities in aging. It is the place to connect with peers, refresh your knowledge and gain new perspectives. We invite you to join our conference community of nearly 3,000 multidisciplinary professionals who, like you, are working to improve the lives of older adults.

Visit us at booth 816 to learn more about the ADDF and its site Cognitive Vitality, which was launched to help people make informed decisions about brain health. Our expert neuroscientists evaluate the available evidence on strategies to promote brain health and prevent dementia. Contents include first steps to protect your cognitive vitality, blog posts on news related to dementia prevention, and unbiased ratings of food, drinks, supplements, and drugs for potential benefit, evidence, and safety.

Premiere Women’s Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Premiere Women’s Luncheon

Premiere Women’s Luncheon

March 13, 2018

12:00–2:30 pm

 

Club Colette
215 Peruvian Avenue
Palm Beach, FL

This elegant luncheon, honoring Kim Campbell, raised funds for Alzheimer's drug research and featured Dr. Roberta Diaz Brinton, an expert on the aging female brain and regenerative therapeutics, and Dr. Howard Fillit, ADDF's Chief Science Officer.

For more information, please contact rsvp@alzdiscovery.org.

LEADERSHIP


EVENT CHAIRS

  • Ashley Campbell
  • Nancy Goodes
  • Jan Willinger

Stay Updated on the ADDF's Upcoming Special Events

Sign up today to receive news and invitations by email.

Sip & Shop at J.McLaughlin in Palm Beach | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughlin in Palm Beach

Sip & Shop at J.McLaughlin in Palm Beach

February 22, 2018

5:00 - 7:00 pm

 

J.McLaughlin
225 Worth Avenue
Palm Beach, FL

Join hosts Nancy Goodes and Jan Willinger at classic American clothier J.McLaughlin's Palm Beach location for a fun evening of light bites, drinks, and shopping.

J.McLaughlin will donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer's and related dementias.


Stay Updated on Where the ADDF Will Be Next

Sign up today for emails about our upcoming events.

12th Annual Drug Discovery for Neurodegeneration Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

12th Annual
Drug Discovery for Neurodegeneration Conference

12th Annual Drug Discovery for Neurodegeneration Conference

February 4-6, 2018

 

The Ritz-Carlton,
Pentagon City
1250 South Hayes Street
Arlington, VA

An Educational Course on Translating Research into Drugs

Designed as a comprehensive course, this didactic conference educates scientists on the processes of translating basic research into novel therapies and leaves participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The programs also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to neurodegeneration. The program includes sessions for networking, partnering/mentoring, and posters presented by young investigators.

Speakers

William Banks, University of Washington
Kurt Brunden, University of Pennsylvania
Marcie Glicksman, Orig3n, Inc.
Mark Gurney, Tetra Discovery Partners
Daniel Javitt, Columbia University Medical Center
Frank Longo, Stanford University, PharmatrophiX
Kenneth Marek, The Institute for Neurodegenerative Disorders
Leslie Meyer-Leon, IP Legal Strategies Group PC
Richard Mohs, Global Alzheimer's Platform
Len Petrucelli, Mayo Clinic
Rana Quraishi, University of Maryland Ventures
Lorenzo Refolo, National Institute on Aging
Amy Ripka, Lucy Therapeutics
Sharon Rosenzweig-Lipson, AgeneBio
Tarek Samad, Pfizer
Barbara Slusher, Johns Hopkins Drug Discovery Center
Edward Spack, Vector BioSolutions
Claire Steppan, Pfizer
Amir Tamiz, National Institute of Neurological Disorders and Stroke
D. Martin Watterson, Northwestern University
Caroline Zeiss, Yale University


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

ADDF to Exhibit at the Society for Neuroscience Annual Meeting 2017 | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF Exhibiting at
The Society for Neuroscience Annual Meeting

ADDF to Exhibit at the Society for Neuroscience Annual Meeting 2017

November 11-15, 2017

 

Walter E. Washington Convention Center
Washington, DC

Come visit the ADDF at booth 3338 at the 47th Annual SfN Meeting! Meet with our leading team of neuroscientists to talk about your projects, learn about our educational opportunities, and get information on the ADDF ACCESS program.

FTD Social: A Neuroscience 2017 Satellite Event

November 11 at 6:30 pm
Renaissance Washington, DC Downtown Hotel, Room 3, 999 Ninth Street NW

Join us for an informal evening with FTD researchers hosted by the Association for Frontotemporal Degeneration and co-sponsored by the ADDF, American Brain Foundation, CurePSP, and Tau Consortium. 


Get Updates on Where the ADDF will be Next

Sign up to receive news by email.

Holiday Bazaar at Hôtel Plaza Athénée | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Benefit Shopping Event
Holiday Bazaar

Holiday Bazaar at Hôtel Plaza Athénée

November 7-8, 2017

10:00 am - 6:00 pm

 

Hôtel Plaza Athénée
37 East 64th Street
New York, NY

Join us for the Holiday Shopping Bazaar at New York's Hôtel Plaza Athénée in the Trianon Room. This annual event features exclusive gifts from around the world, perfect for holiday gift giving. 

And 10% of the proceeds from the two-day shopping event will be donated to the Alzheimer's Drug Discovery Foundation in support of our mission to conquer Alzheimer's. The Holiday Bazaar is organized by our friends at DKF Enterprises. Some of the items that will be available are: 

  • DKF ENTERPRISES, LTD.: Gifts & Accessories
  • BOO GEMES: Fun Cashmere Capes & Holiday Accessories
  • BALUDESIGNS by Jane Veronis: Jewelry from Spain & New York
  • CHARLOTTE B: Bespoke Fur Parkas & Affordable Fine Jewelry  
  • KJ LONDON: Bespoke Handbags with Amusing Quotations
  • MARIA SCOTTO: Italian Lingerie
  • PAMELA DUTTON: Exquisite Accessories Featuring Horn, Bone & Wood combined with Pearls & Semi-Precious Stones 
  • W. H. PETRONELA: Timeless Handbags Designed to Last a Lifetime.
  • YUTA POWELL: Luxury & Distinctive Style Clothing from Europe

Stay Updated on Shopping Events that Support the ADDF

Sign up today to receive emails about upcoming partner events.

2017 TCS New York City Marathon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

2017 TCS New York City Marathon

2017 TCS New York City Marathon

November 5, 2017

 


New York, NY

The ADDF is proud to be an official charity partner for the 2017 TCS New York City Marathon. Donations to our team, Runners for Alzheimer's Research, directly support research into new treatments for this devastating disease. In 2016, our eighteen team members raised over $100,000, far surpassing their goal.

Thank you to everyone who showed their support for our 2017 runners!

Read why one team member chose to run for the ADDF.

What All Team Members Receive

• Guaranteed entry into the 2017 TCS New York City Marathon
• Personalized 12- or 16-week online training plan based on your fitness level and running experience
• Fundraising tips and support, including a personal fundraising page to help you meet your goals
• Custom ADDF tech shirt for race day
• Opportunities to join team runs and events throughout the year
• Pre-race team dinner

Fundraising Commitment

Runners for Alzheimer's Research team members commit to raising a minimum of $3,000, due in full by October 27, 2017. In addition to the fundraising pledge, all runners are responsible for the TCS New York City Marathon race registration fees.

100% of donations raised by our team will go directly to drug discovery research for Alzheimer's and related dementias.

EVENT SPONSORS


  • Wristband Creation

Stay Updated on Our Upcoming Events

Sign up today to receive information on the ADDF's events.

Eighth Annual Fall Symposium & Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Eighth Annual
Fall Symposium & Luncheon

Eighth Annual Fall Symposium & Luncheon

October 27, 2017

10:30 am | Symposium

12:00 pm | Luncheon

 

The Pierre
New York, NY

The Eighth Annual Fall Symposium & Luncheon "Hope on the Horizon," hosted by Emmy Award-winning journalist Paula Zahn, honored Sharon T. Sager, chairman of our Board of Overseers, for her heroic efforts on behalf of dementia research.

The event began with the morning symposium "Spotlight on Alzheimer's Clinical Trials," moderated by Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF. Panelists included:

  • Mark Gurney, PhD, Chairman and CEO, Tetra Discovery Partners, Inc.
  • Leen Kawas, PhD, President and CEO, M3 Biotechnology
  • Jerri M. Rook, PhD, Assistant Professor of Pharmacology, Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University

All proceeds from Hope on the Horizon support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer's and related diseases.

For more information, contact RSVP@alzdiscovery.org.

LEADERSHIP


EVENT LEADERSHIP SUPPORT

  • Colliers International NY LLC
  • Joyce B. Cowin
  • The Estée Lauder Companies Inc.
  • Marilyn and Sam Fox
  • Nancy and Mel Goodes
  • Janet Prindle Seidler Foundation
  • Jo Carole and Ronald S. Lauder
  • Judy and Leonard A. Lauder
  • Susan Lloyd
  • Sharon T. Sager and J. Loring Swasey
  • Samuel I. Newhouse Foundation, Inc.
  • Patrick Shaw, Ehrenkranz Partners
  • The Sheldon H. Solow Foundation
  • Laura and Stephen Toma
  • UBS
  • Wendy Wilshin and Ronald Dickerman

Host Committee

Christopher Amo
Carol Seabrook Boulanger
Charlie Cangro
Carole Cooper and
    Richard Leibner
Hillary Cullen and Paul Bruder
John Demsey
The Dolby Family
Bonnie Pfeifer Evans
Mary C. Farrell
David Gerson
Wendy Holmes
Audrey and Martin Gruss
Agnes Gund
Kiera and Chris Johnson
Eleanora Kennedy
Deborah and Peter Krulewitch
Laura and Gary Lauder
Bonnie Englebardt Lautenberg
Larry Leeds
Philip Lovett

Carlyn S. McCaffrey
Alison McCall and Peter Eliel
Heidi and Tom McWilliams
Julie Medler
Louise Pesale
Phebe Farrow Port
Ann Marie and Jeffrey Sager
Liz and Randal Sandler
Frances G. Scaife
Steven Schnook and Frank Webb
Christa and Greg Schwartz
John Scully
Patrick Shaw
Alice Shure
David Sirianni
J. Loring Swasey
Laura and Steven Toma
Carol and Michael Weisman
Jan Willinger
Eric Wittenberg
Paula Zahn

Health Research Alliance Members’ Meeting | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Members' Meeting
Health Research Alliance

Health Research Alliance Members’ Meeting

September 17-18, 2017

 

Swissotel Chicago
Chicago, IL

Andrew Koemeter-Cox, the ADDF's Scientific Program Officer, joins the panel "Accelerating Treatments to Patients – Crossing the Valley of Death," at the 2017 Health Research Alliance meeting. The panel, which is moderated by Diane Bovenkamp, PhD, BrightFocus Foundation, describes the path of new drugs, from an idea to a drug that can be tested in patients. Panelists will discuss toxicology testing, drug manufacturing, and formulation as well as funding, commercialization, and regulatory issues. The panel's focus in on the role of foundations in moving treatments forward to human clinical trials. 


Get Updates on Where the ADDF will be Next

Sign up to receive news by email.

Sip & Shop at J.McLaughin | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughin

Sip & Shop at J.McLaughin

September 14, 2017

6:00 - 8:00 pm

 

J.McLaughlin
Washington, D.C.

Don't miss our inaugural event at partner J.McLaughlin's Georgetown location! Enjoy wine and light snacks while shopping the Fall 2017 Collection from the classic American clothier.

And everything you purchase benefits lifesaving research! J.McLaughlin will donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer’s and related dementias.


Get the Latest on Where the ADDF Will Be Next

Sign up today for emails about the ADDF's upcoming events.

18th International Conference on Alzheimer’s Drug Discovery | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

18th International
Conference on Alzheimer's Drug Discovery

18th International Conference on Alzheimer’s Drug Discovery

September 11-12, 2017

 

Hyatt Regency
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer's disease and related dementias. The ADDF's funded investigators and leading scientists in the field present their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

The 2017 program was organized into four sessions.

Session 1: Neuroinflammation

Talks will highlight unique neuroinflammation targets and repurposing opportunities relevant to inflammation.

Presenters include:
• Jurgen Claassen, PhD, Radboud University
• Alpaslan Dedeoglu, MD, PhD, Boston University School of Medicine
• Milton Greenberg, PhD, Vivreon Biosciences
• Philip Haydon, PhD, GliaCure
• D. Martin Watterson, PhD, Northwestern University

Session 2: Neuroprotection and Neural Regeneration

Talks will highlight therapeutic approaches targeting neurotrophic factors or hormones that promote neuronal survival, strategies to convert neural stem cells into mature neurons, and approaches to prevent neuronal death.

Presenters include:
• Roberta Diaz Brinton, PhD, University of Arizona Health Sciences
• Travis Dunckley, PhD, Arizona State University
• Leen Kawas, PhD, M3 Biotechnology
• Michael Peel, PhD, Cypralis, Ltd.
• William J. Ray, PhD, The Neurodegeneration Constortium, MD Anderson
• Yan Jessie Zhang, PhD, University of Texas, Austin

Session 3: Epigenetics and Cognitive Enhancing

Talks will highlight advances in epigenetic therapeutics, comparative effectiveness research, and drug repurposing in treating or preventing cognitive symptoms associated with Alzheimer's, mild cognitive impairment, and aging.

Presenters include:
• Lenore Launer, PhD, Intramural Research Program, National Institute on Aging
• Allan Levey, MD, PhD, Emory University
• Tamara Maes, PhD, Oryzon Genomics S.A.
• Ana Pereira, MD, The Rockefeller University
• Maria Quinton, PhD, Rodin Therapeutics
• Neil Vasdev, PhD, Massachusetts General Hospital

Session 4: Misfolded Proteins and Proteostasis

Talks will highlight drug discovery programs pursuing innovative routes towards solving the problem of misfolded proteins and protein accumulation, along with biomarker programs under development.

Presenters include:
• Steven Finkbeiner, MD, PhD, Gladstone Institute of Neurological Disease, UCSF
• Brent Stockwell, PhD, Columbia University
• Dominic Walsh, PhD, Brigham & Women's Hospital
• Xinglong Wang, PhD, Case Western Reserve University School of Medicine


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Sip & Shop at J.McLaughlin | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughlin

Sip & Shop at J.McLaughlin

September 7, 2017

6:00 - 8:00 pm

 

J.McLaughlin
New York, NY

Shop for a cause! Join us for a fun evening of light bites and drinks while you shop the Fall 2017 Collection from classic American clothier J.McLaughlin at its 1004 Lexington Avenue location. 

J.McLaughlin will generously donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer’s and related dementias.


Get the Latest on Our Upcoming Events

Sign up today for emails about the ADDF's events.

Public Policy and the Coming Epidemic of Neurodegenerative Disease | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Public Policy and the Coming Epidemic of Neurodegenerative Disease

Public Policy and the Coming Epidemic of Neurodegenerative Disease

June 20, 2017

1:45 - 2:45 pm PST

 

2017 BIO International Convention, Rm 7A
San Diego, CA

Dr. Lauren Friedman, our Assistant Director, Scientific Affairs, joins this panel moderated by MacKay Jimeson, Corporate Affairs, Pfizer Internal Medicine. The panel will discuss the policy landscape for neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, and the ways it must evolve as science advances. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and/or death of nerve cells. Globally, some countries have enacted policies and programs to support education, screening programs and improved care for patients with neurodegenerative disorders. This session will explore the evolving neurodegenerative disease policy environment, including legislative initiatives and local country examples of policies that have been enacted to support the needs of people with these disorders. Panelists will highlight the evolution of various neurodegenerative disease policy efforts in areas such as research, regulatory, awareness and recognition, diagnosis, coordination of care, treatment availability and ongoing management.

Upon Reflection: Photographs by Judy Glickman Lauder | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Upon Reflection: Photographs by Judy Glickman Lauder

Upon Reflection: Photographs by Judy Glickman Lauder

April 7–May 20, 2017

 

Howard Greenberg Gallery
New York, NY

Upon Reflection: Photographs by Judy Glickman Lauder is on view at Howard Greenberg Gallery from April 7–May 20, 2017. The exhibition features the artist's recent work—subtle and poetic self-portraits and abstractions in dreamlike settings and distilled urban landscapes. Through Judy Glickman Lauder's generous support, proceeds from the exhibition's sales will benefit the ADDF and our mission to conquer Alzheimer's. 

Over the past five years, Glickman Lauder has worked using only natural light to capture reflections and shadows that become abstractions often including self-portraits that are slightly hidden, some revealed only upon closer examination. The large prints are drenched in color, with intricate patterns and intriguing perspectives. The series represents a transition for Glickman Lauder. "My work in color has sent me in another direction—one of exploration and of introspection," she notes.

Glickman Lauder, whose career began in the 1970s, is best known for black-and-white imagery. Her photography, which has been exhibited extensively at over 150 major museums and galleries, will be seen this fall in the Jewish Museum's Masterpieces & Curiosities: Theresienstadt Bracelet exhibition.

 

Image: Venice, Italy, 1997 © Judy Glickman Lauder. Courtesy Howard Greenberg Gallery.

Eleventh Annual Connoisseur’s Dinner | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Eleventh Annual
Connoisseur's Dinner

Eleventh Annual Connoisseur’s Dinner

May 10, 2017

6:30 pm | Cocktails

7:30 pm | Dinner

Black Tie

 

Sotheby's, 1334 York Avenue
New York, NY

Our annual gala featured highlights of Sotheby's Spring Impressionist & Modern Art and Contemporary Art exhibition, a delicious selection of wines presented by Sotheby's, and our lively "Fund a Scientist" Auction, which gives guests a special opportunity to support the ADDF's promising Alzheimer's research. We also presented the annual Chairman's Award to Tad Smith, President and CEO, Sotheby's, who accepted on behalf of Sotheby's. This award was established by our Co-Chairmen Leonard A. Lauder and Ronald S. Lauder to recognize a prominent leader who is advancing our efforts to prevent, treat, and ultimately cure Alzheimer's disease.

EVENT SPONSORS


  • Beacon Trust
  • Bloomberg Philanthropies
  • Estee Lauder Companies
  • EY
  • J.P.Morgan
  • Macy's, Inc.
  • Mount Sinai Health System
  • Nucor
  • Pfizer
  • Sotheby's

LEADERSHIP


Executive Chairs

  • Jo Carole and Ronald S. Lauder
  • Judy and Leonard A. Lauder
  • Lady Lynn Forester de Rothschild and
      Sir Evelyn de Rothschild
  • Liz and Randal Sandler
  • Sotheby's

Founding Chair

  • Nancy Corzine

Co-Chairs

  • The Calvin Klein Family Foundation
  • Nancy and Melvin R. Goodes
  • Samuel I. Newhouse Foundation

Vice Chairs

  • Beacon Trust
  • Bloomberg Philanthropies
  • Carol Seabrook Boulanger
  • Rose Marie Bravo and William Jackey
  • CB Richard Ellis
  • The Estée Lauder Companies Inc.
  • EY
  • Julie and Phil Geier
  • J.P. Morgan
  • Bonnie Englebardt Lautenberg
  • Macy's, Inc.
  • The Margaret and Daniel Loeb - Third Point Foundation
  • Mount Sinai Health System
  • Nancy and Howard Marks
  • Nucor Construction Corp.
  • Pfizer Inc.
  • The Sheldon H. Solow Foundation
  • Pam and Allen B. Swerdlick
  • Carol and Michael Weisman
  • Wendy Wilson and Ronald Dickerman
Seventh Annual Great Ladies Luncheon & Fashion Show | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Seventh Annual
Great Ladies Luncheon & Fashion Show

Seventh Annual Great Ladies Luncheon & Fashion Show

April 26, 2017

10:30 am | Symposium

12:00 pm | Luncheon

 

The Ritz-Carlton
Washington, DC

The Alzheimer's Drug Discovery Foundation and Neiman Marcus Mazza Gallerie presented the Seventh Annual Great Ladies Luncheon & Fashion Show, hosted by PBS NewsHour anchor Judy Woodruff. At this year's luncheon, we were thrilled to present the Great Ladies Award to esteemed author and journalist Sally Quinn for her contributions to the fight against Alzheimer's disease. Guests at the event enjoyed a rare runway show by Italian designer Brunello Cucinelli.

The Luncheon was preceded by the Symposium to Conquer Alzheimer's, featuring a panel of leading scientists led by Howard Fillit, MD. The Symposium was hosted by Andrea Mitchell, NBC News anchor and Chief Foreign Affairs Correspondent. 

The Great Ladies Luncheon is generously underwritten by Elise Lefkowitz.

For more information, please contact rsvp@alzdiscovery.org.

EVENT SPONSORS


  • Estee Lauder Companies
  • Neiman Marcus
  • Brunello Cucinelli

LEADERSHIP


Founding Executive Chairs

  • Elise and Marc Lefkowitz
  • Leonard A. Lauder
  • Ronald S. Lauder

Honorary Chairs

  • The Ambassador of Italy and Mrs. Armando Varricchio

Executive Chairs

  • Pennie Abramson
  • Faith Bobrow
  • Julie C. Opperman
  • Thomas Pheasant

Vice Chairs

  • Shelley and Robby Banks
  • Grace and Morton Bender
  • Nancy Taylor Bubes
  • Nancy and Marc Duber
  • Liz Dubin
  • Goodes Family Foundation
  • Katy Kamen
  • Patricia Bennett Sagon

Ladies Benefit Committee Co-Chairs

  • Shelley Banks
  • Nancy Taylor Bubes
  • Andrea Mitchell
  • Kelly Ripken
  • Patricia Bennett Sagon

Gentlemen's Benefit Committee Chair

  • Marc D. Lefkowitz

Ladies Benefit Committee

Pennie Abramson
Lise Adkins
Lauren Mason Ali
Tina S. Alster, MD
Amy Baier
Lisa B. Beek
Grace Bender
Tracy Bernstein
Wilma Bernstein
Admiral Susan Blumenthal, MD
Faith Bobrow
Evelyn T. Brandt
Jill Brigati
Buffy Cafritz
Lynda Camalier
Connie Carter
Lynda Carter
Sharon Collins Casey
Kristin Rae Cecchi
Marcella Cohen
Meryl Comer
Lizette Corro
Charlie Lefkowitz Crowley
Alexandra de Borchgrave
Debbie Dingell
Martha Dippell
Nancy Duber
Liz Dubin
Deborah L. Epstein
Samia Farouki
Ann Free
Debra Friedmann
Elizabeth W. Galvin
Alma Gildenhorn
Beth Glassman

Nancy Goodes
Sarah G. Gund
Ann Hand
Raeanne Hytone
Cindy Jones
Katy Kamen
Mary Ann Kibarian
Phyllis L. Kim
Diana Kogan
Dana Landow
Willee Lewis
Marlene A. Malek
Dobra Marshall
JoAnn Mason
Barbara McInerney
Elaine Miller
Laurie Monahan
Melanie Nussdorf
Mary Ourisman
Karen Paganelli
Ginger Pickle
Diane Powell
Jaclyn Mason Randall
Genevieve McSweeney Ryan
Marilou Sanford
Bonnie Staffier
Liz Underhill
Toni Verstandig
Lorraine Wallace
Anne Hatfield Weir
Dr. Tina B. West
Cathy Merrill Williams
Carol Gildenhorn Winer
Delores Wolf

 

Gentlemen's Benefit Committee

Jeffery Ashin
Philip Bobrow, MD
Davis Camalier
Shane Crowley
David Deckelbaum
Marc Duber
Amb. Paul D. Frazer
Brian Friedman
Jim Glassman
Israel Kogan
Michael Landow
Matthew Lefkowitz

Adam Mahr
Bennett R. Marshall
John J. Mason
William Miller
Thomas Pheasant
Hon. Edward A. Powell
Tony Powell
Bruce Rashbaum
Sonny Small
Andre Spearman
Fabio Trabocchi

5th Annual Brain Awareness Fair | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

5th Annual
Brain Awareness Fair

5th Annual Brain Awareness Fair

March 14, 2017

POSTPONED UNTIL FURTHER NOTICE

 

Mount Sinai, Guggenheim Pavilion
New York, NY

Due to the weather, this event has been POSTPONED. It will BE rescheduled for a later date.

Join us at Mount Sinai's 5th Annual Brain Awareness Fair during Brain Awareness Week. Scientists from the Alzheimer's Drug Discovery Foundation will be on hand to share important brain health facts, lead interactive games, and answer all your questions about Alzheimer's and dementia prevention and treatment.

The Brain Awareness Fair is held each year in the Guggenheim Pavilion at Mount Sinai Hospital. Exhibits and activities included pipe cleaner neuron models, a 3D surgery simulator, a Meet the Experts booth featuring prominent neuroscientists, and the MegaBrain, the world’s only portable, inflatable, walk-through brain exhibit. Don't miss it! 

Protect Your Brain, Prevent Dementia: A Brain Awareness Week Event | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

A Brain Awareness Week Event
Protect Your Brain, Prevent Dementia

Protect Your Brain, Prevent Dementia: A Brain Awareness Week Event

March 13, 2017

6:30 - 8:00 pm

Free Admission

 

Hunter College
New York, NY

Celebrate Brain Awareness Week 2017 in New York with the Alzheimer's Drug Discovery Foundation! 

At this event, our expert scientists will share ways you can reduce your risk for Alzheimer's disease and protect your brain health. The evening will include a presentation, interactive exhibits with information on brain health and dementia prevention, and a question and answer session. Learn what the evidence says about which supplements, diets, and lifestyle changes can benefit your brain. And discover promising drugs now being developed that may prevent and treat Alzheimer's disease and other dementias. 

The event is free to all, but registration is requested. 

Directions

Hunter College Main Campus
West Building, 3rd Floor Cafeteria
Enter at SW corner of 68th Street and Lexington Avenue

EVENT SPONSORS


  • braiNY
  • Hunter College
Sip & Shop at J.McLaughlin | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughlin

Sip & Shop at J.McLaughlin

February 23, 2017

5:00 - 7:00 pm

 

J.McLaughlin
Palm Beach, FL

Over the President's Day holiday, join us at classic American clothier J.McLaughlin's Palm Beach location for light bites and drinks. 

J.McLaughlin will donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer’s and related dementias.

11th Annual Drug Discovery for Neurodegeneration Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

11th Annual
Drug Discovery for Neurodegeneration Conference

11th Annual Drug Discovery for Neurodegeneration Conference

February 12-14, 2017

 

DoubleTree by Hilton Hotel San Diego – Mission Valley
San Diego, CA

An Educational Course on Translating Research into Drugs

Designed as a comprehensive course, this didactic conference educates scientists on the processes of translating basic research into novel therapies and leaves participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The programs also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to neurodegeneration. The program includes sessions for networking, partnering/mentoring, and posters presented by young investigators.


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Seventh Annual Fall Symposium & Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Seventh Annual
Fall Symposium & Luncheon

Seventh Annual Fall Symposium & Luncheon

November 14, 2016

10:30 am | Symposium

12:00 pm | Luncheon

Business Attire

 

The Pierre
New York, NY

Join us for the Seventh Annual Fall Symposium & Luncheon "Hope on the Horizon," hosted by Emmy Award-winning journalist Paula Zahn. At this year's luncheon, we are thrilled to honor philanthropist and President of Advance Publications, Inc., Donald E. Newhouse, for his commitment to dementia research. The morning symposium will feature Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF, and a panel of leading scientists discussing the connections between Alzheimer's and other diseases such as frontotemporal dementia and Parkinson's and the drugs currently in clinical trials that hold promise for multiple diseases. 

All proceeds from Hope on the Horizon support the ADDF's mission to accelerate the discovery and development of drugs to prevent, treat, and cure Alzheimer’s and related diseases.

Symposium Panelists

Sandra E. Black, OC, O.Ont, MD, FRCP(C)
Brill Chair in Neurology, Department of Medicine, Sunnybrook Health Sciences Center & University of Toronto
Executive Director, Toronto Dementia Research Alliance

Carlos Buesa, PhD
CEO, Oryzon Genomics

Michela Gallagher, PhD
Krieger-Eisenhower Professor, Johns Hopkins University with joint appointments in Neuroscience and Psychology Departments

Edward D. Huey, MD
Assistant Professor of Psychiatry and Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Columbia University

EVENT SPONSORS


  • Estee Lauder Companies
  • Staples Business Advantage
  • Eli Lilly

LEADERSHIP


Executive Chairs

  • Renée and Robert Belfer
  • Nancy and Mel Goodes
  • The Lauder Foundation — Leonard & Judy Lauder Fund
  • Jo Carole and Ronald S. Lauder
  • Samuel I. Newhouse Foundation, Inc.
  • Liz and Randal Sandler

Honorary Chairs

  • Bonnie Pfeifer Evans
  • Alice Shure

Co-Chairs

  • The Altec-Styslinger Foundation,
        Jennifer and Mark Styslinger
  • Eli Lilly and Company
  • The Estée Lauder Companies Inc.
  • Julie and Phil Geier
  • Howard Kaneff
  • Mitchell Kaneff
  • Susan Lloyd
  • Staples Business Advantage

Vice Chairs

  • Arcade Beauty
  • Colliers International NY LLC
  • Ehrenkranz Partners
  • Liz and George Krupp
  • Neiman Marcus Group
  • Laura and Stephen Toma

Host Committee

  • Renée and Robert Belfer
  • Carole Cooper and Richard Leibner
  • Joel S. Ehrenkranz
  • Julie and Phil Geier
  • David Gerson
  • US Senator Kirsten Gillibrand
  • Nancy and Mel Goodes
  • Deborah and Peter Krulewitch
  • Liz and George Krupp
  • William P. Lauder
  • Bonnie Englebardt Lautenberg
  • Larry Leeds
  • Susan and Tom Lowder
  • Carlyn S. McCaffrey
  • Laura and Stephen Toma
  • Carol and Michael Weisman
  • Jan Willinger and Robert Spiegel
  • Paula Zahn
ADDF to Exhibit at the Society for Neuroscience Annual Meeting 2016 | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF Exhibiting at
The Society for Neuroscience Annual Meeting

ADDF to Exhibit at the Society for Neuroscience Annual Meeting 2016

November 12-16, 2016

 

San Diego Convention Center
San Diego, CA

Come visit the ADDF team at the 46th Annual SfN Meeting in Booth 3800! Learn more about our upcoming conferences, grant opportunities, ADDF ACCESS program, and much more!


Get Updates on Where the ADDF will be Next

Sign up to receive news by email.

2016 TCS New York City Marathon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

2016 TCS New York City Marathon

2016 TCS New York City Marathon

November 6, 2016

 


New York, NY

The ADDF was once again selected as an official charity partner for the TCS New York City Marathon. Donations to our team, Runners for Alzheimer's Research, directly support research into new treatments for this devastating disease. In 2015, our eight team members raised nearly $85,000, far surpassing their goal. 

Though we are making great strides, Alzheimer's remains the only top 10 cause of death in the U.S. that can't be prevented, cured, or even slowed. By supporting our team, Runners for Alzheimer's Research, you will help us further our mission to rapidly accelerate the discovery of drugs to prevent and treat Alzheimer's disease.

Read about why one team member, Ernest Scheyder, is running for the ADDF.

Please note that the Alzheimer's Drug Discovery Foundation is no longer accepting applications for invitational entry into the 2016 TCS New York City Marathon.

17th International Conference on Alzheimer’s Drug Discovery | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

17th International Conference on Alzheimer’s Drug Discovery

17th International Conference on Alzheimer’s Drug Discovery

September 12-13, 2016

 

Hyatt Regency
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF's funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering.

This Year's Speakers

• Dirk Beher, Aceneuron
• Elizabeth Bradshaw, Brigham and Women's Hospital
• Carol Colton, Duke University Medical Center
• Mari DeMarco, University of British Columbia
• Pontus Forsell, AlzeCure Foundation
• Michael Gold, PPD
• Atticus Hainsworth, St. George, University of London
• Ihab Hajjar, Emory University
• Mansuo Hayashi, Eli Lilly and Company
• Lawrence Honig, Columbia University
• Edward Huey, Columbia University
• Berkley Lynch, Rodin Therapeutics
• Alexandros Makriyannis, Northeastern University
• Yukari Perrella, Yuma Therapeutics
• Jerri Rook, Vanderbilt Center of Neuroscience Drug Discovery
• Sharon Rosenzweig-Lipson, AgeneBio
• Stephen Salton, Icahn School of Medicine at Mount Sinai
• Grace Stutzmann, Rosalind Franklin University of Science and Medicine
• Paul Thompson, University of Massachusetts
• Raymond Scott Turner, Georgetown University
• Shijun Zhang, Virginia Commonwealth University
• Danna Zimmer, University of Maryland School of Medicine


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Sip & Shop at J.McLaughlin | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sip & Shop at J.McLaughlin

Sip & Shop at J.McLaughlin

September 8, 2016

6:00 - 8:00 pm

 

J.McLaughlin
New York, NY

Join us for light bites and drinks while you shop the Fall 2016 Collection from classic American clothier J.McLaughlin at its 1004 Lexington Avenue location. 

J.McLaughlin will donate 15% of all sales during the event to benefit the ADDF and our mission to accelerate drugs to prevent, treat, and cure Alzheimer’s and related dementias.

For those unable to attend, the store will donate for purchases made all weekend when you mention the ADDF.

Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Surgery and Cognition:
Delirium, Cognitive Decline, and Opportunities to Protect the Brain

Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

June 21, 2016

8:00 am - 5:00 pm

 

The New York Academy of Sciences
New York, NY

Surgery helps millions of Americans overcome illness and live longer, healthier lives. Yet for many patients, surgery can also lead to delirium, cognitive decline, and perhaps even a higher long-term risk of dementia. These risks are poorly understood and often underrecognized in the clinic. The level of risk to a patient depends on the individual and the surgery. For example, delirium is experienced in 15–80% of surgical patients who, in turn, may have a higher risk of long-term cognitive and functional decline.

This one-day meeting, presented by the Alzheimer's Drug Discovery Foundation and the Brain Dysfunction Discussion Group, will convene leading scientists to discuss the challenges and opportunities to create biomarkers and therapeutics for these vulnerable patients.

Nexus of Alzheimer’s, Related Dementias & Cancer | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Nexus of Alzheimer’s, Related Dementias & Cancer

Nexus of Alzheimer’s, Related Dementias & Cancer

May 25, 2016

8:00 am - 5:00 pm

 

Park Hyatt
Washington, D.C.

This meeting, organized by the Alzheimer's Drug Discovery Foundation and Alzheimer’s Association, delved into the biological underpinnings that may explain the linkage between cancer and Alzheimer’s. It also provided new avenues for drug discovery.

Sessions focused on current insights from epidemiology, mechanistic and genetic links between cancer and Alzheimer's disease, and therapeutic implications. The goal was to identify specific research questions and linkages needed to advance treatments for Alzheimer's.

1st European Drug Discovery for Neurodegeneration Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

1st European Drug Discovery for Neurodegeneration Conference

1st European Drug Discovery for Neurodegeneration Conference

May 15-17, 2016

 

The Danubius Health Spa Resort
Budapest, Hungary

We are hosting our first European conference on Drug Discovery for Neurodegeneration: An Educational Course on Translating Research into Drugs which is based on the ADDF’s annual US-based Drug Discovery for Neurodegeneration conference, which was established in 2007 to meet the following objectives:

  1. Train a cadre of interdisciplinary scientists in the principles of drug discovery for neurodegenerative disease (NDD)

  2. Provide a platform to exchange ideas, knowledge and resources about drug discovery for NDD

  3. Stimulate preclinical research in the discovery and testing of novel compounds aimed at the prevention and treatment of NDD

  4. Build public-private partnerships that will accelerate drug discovery for NDD

This didactic conference will educate scientists on the processes of translating basic research into novel therapies and will leave participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The program will also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to NDD.


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

Tenth Annual Connoisseur’s Dinner | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Tenth Annual
Connoisseur’s Dinner

Tenth Annual Connoisseur’s Dinner

April 28, 2016

6:00 pm | Cocktails

7:30 pm | Dinner

Black Tie

 

Sotheby's, 1334 York Avenue
New York, NY

Join us for our annual gala, which will honor Ronald S. Lauder for his visionary leadership in supporting new treatments for Alzheimer's. The Connoisseur's Dinner will feature an exclusive preview of Sotheby’s Spring Impressionist, Modern and Contemporary Art Sale, with wine pairings presented by Sotheby’s and a live Fund a Scientist Auction conducted by Jamie Niven.

EVENT SPONSORS


  • Avenue Magainze
  • Estee Lauder Companies
  • EY
  • JP Morgan
  • Macy's Inc
  • Northern Trust
  • Nucor Construction Corp
  • Pfizer
  • Sotheby's
  • Tishman Speyer

LEADERSHIP


Executive Chairs

  • Anonymous
  • The Lauder Foundation
    — The Leonard and Judy Lauder Fund
  • The Ronald and Jo Carole Lauder Foundation
  • Sir Evelyn and Lady Lynn Forester de Rothschild
  • Mr. and Mrs Randal B. Sandler

Co-Chairs

  • Mr. and Mrs. Robert J. Appel
  • Blavatnik Family Foundation
  • The Calvin Klein Family Foundation
  • Ms. Nancy Corzine
  • Mr. and Mrs. Melvin R. Goodes
  • Mrs. Judy Glickman Lauder
    and all of the Glickman Family
  • Mr. and Mrs. Chris Reyes

Vice-Chairs

  • Ms. Carol Seabrook Boulanger
  • Ms. Rose Marie Bravo
  • Ms. Caryn Clayman
  • EY
  • J.P. Morgan
  • Mr. and Mrs. Gary Lauder
  • Mrs. Bonnie Englebardt Lautenberg
  • Macy's and Bloomingdale's
  • Mr. and Mrs. Howard Marks
  • Mr. Donald E. Newhouse
  • The Northern Trust Company
  • Nucor Construction Corp.
  • Pfizer Inc.
  • The Ralph and Ricky Lauren Family Foundation
  • Mr. and Mrs. Olivier Reza
  • Ms. Lois Robbins and Mr. Andrew Zaro
  • Mr. and Mrs. Peter J. Solomon
  • Sotheby's
  • Mr. and Mrs. Andrew Tisch
  • Tishman Speyer
  • Thomas H. Lowder Family Foundation
  • Mr. and Mrs. Michael Weisman
  • Ms. Wendy Wilson and Mr. Ronald Dickerman
Sixth Annual Great Ladies Luncheon & Fashion Show | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sixth Annual
Great Ladies Luncheon & Fashion Show

Sixth Annual Great Ladies Luncheon & Fashion Show

April 13, 2016

10:45 am | Scientific Presentation

12:00 pm | Fashion Show & Luncheon

2:00 pm | Oscar de la Renta Trunk Show

Business Attire

 

The Ritz Carlton
Washington, DC

The Alzheimer’s Drug Discovery Foundation and Neiman Marcus Mazza Gallerie presented the Sixth Annual Great Ladies Luncheon & Fashion Show, honoring Trish and George Vradenburg for their contributions to the fight against Alzheimer's disease. Guests at the event, hosted by Chris Wallace, enjoyed a special presentation of Oscar de la Renta's Fall 2016 Collection.

EVENT SPONSORS


  • Estee Lauder Companies
  • FedEx
  • Neiman Marcus
  • Oscar de la Renta

LEADERSHIP


Executive Chairs

  • Elise and Marc Lefkowitz
  • Leonard A. Lauder
  • Ronald S. Lauder

Co-Chairs

  • The Estée Lauder Companies, Inc.
  • Thomas Pheasant

Vice-Chairs

  • Shelley and Robby Banks
  • Liz Dubin
  • FedEx
  • Elizabeth W. Galvin
  • Nancy and Mel Goodes
  • Eileen Shields-West
  • Lorraine Wallace

Ladies Executive Committee

Co-Chaired by: Laurie Monahan and Lorraine Wallace

Lise Adkins
Tina S. Alster, MD
Amy Baier
Shelley Banks
Lisa Brandt Beek
Wilma Bernstein
Faith Bobrow
Evelyn Brandt
Jill and Dan Brigati
Nancy Taylor Bubes
Buffy Cafritz
Lynda Camalier
Connie Carter
Lynda Carter
Sharon Collins Casey
Kristin Rae Cecchi
Marcella Cohen
Meryl Comer
Debbie Dingell
Martha Dippell
Nancy Duber
Liz Dubin
Deborah L. Epstein
Samia Farouki
Ann Free
Debra Friedmann
Elizabeth W. Galvin
Alma Gildenhorn

Beth Glassman
Nancy and Mel Goodes
Ann Hand
Raeanne Hytone
Cindy Jones
Mary Ann Kibarian
Diana Kogan
Dana Landow
Willee Lewis
Marlene A. Malek
Dobra and Bennett Marshall
JoAnn and John Mason
Barbara McInerney
Andrea Mitchell
Melanie and Larry Nussdorf
Mary Ourisman
Thomas Pheasant
Ginger Pickle
Patricia Bennett Sagon
Marilou Sanford
Eileen Shields-West
Bonnie Staffier
Shawn Taylor
Anne Hatfield Weir
Dr. Tina B. West
Cathy Merrill Williams
Carol Gildenhorn Winer
Delores Wolf

10th Annual Drug Discovery for Neurodegeneration Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

10th Annual Drug Discovery for Neurodegeneration Conference

10th Annual Drug Discovery for Neurodegeneration Conference

March 6-8, 2016

 

Miami Beach Resort
Miami Beach, FL

Designed as a comprehensive course, this didactic conference educates scientists on the processes of translating basic research into novel therapies and leaves participants with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. The programs also highlight case studies of small molecule and biologics programs at different stages of development aimed at tackling challenging CNS targets relevant to neurodegeneration. The program includes sessions for networking, partnering/mentoring, and posters presented by young investigators.


Get Updates on the ADDF's Upcoming Conferences and Meetings

Sign up to receive news by email.

New York City Drug Discovery Conference | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

New York City Drug Discovery Conference

New York City Drug Discovery Conference

February 12, 2016

 

Apella, Event Space at Alexandria Center
New York, NY

In 2015, we hosted our first New York City Drug Discovery Conference: An Educational Course on Translating Research into Drugs. This one-day meeting educated scientists from varying disciplines on the processes of translating basic research into novel therapies and left them with a strong knowledge base and relevant resources to address the associated barriers and challenges in developing a drug. Holding this meeting in NYC helped to foster the city’s growing biotechnology community, educate academic scientists, and stimulate new partnerships. 

This meeting was based on the ADDF’s annual Drug Discovery for Neurodegeneration Conference, which was established in 2007 to: (1) Train a cadre of interdisciplinary scientists in the principles of drug discovery; (2) Provide a platform to exchange ideas, knowledge and resources about drug discovery; (3) Stimulate preclinical research in the discovery and testing of novel compounds aimed at prevention and treatment; and (4) Build public-private partnerships that will accelerate drug discovery.

Slideshow Presentations by Guest Speakers

Howard Fillit, MD, ADDF

Shari Coulter Ford, MBA, Partnership Fund for New York City

Robert J. DeVita, PhD, Mount Sinai

J. Fraser Glickman, PhD, The Rockefeller University

Sarah J. Schlesinger, MD, The Rockefeller University

DOT, a play by Colman Domingo | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

A play by Colman Domingo
Dot

DOT, a play by Colman Domingo

February 9, 2016

6:00 pm

Tickets $200

 

Vineyard Theatre
New York, NY

Join us for DOT, a play about a family dealing with dementia. Guests will enjoy a special cocktail reception before the show and an exclusive Q & A following the performance with Howard Fillit, MD, Director Susan Stroman, and the cast of Dot. All proceeds from the evening's ticket sales support the ADDF and our mission to accelerate treatment for Alzheimer's disease.

Family matriarch Dotty and her three adult children gather for the holidays with more than exchanging presents on their minds. As Dotty struggles to navigate life with dementia, her children fight to balance care for their mother and care for themselves. A testament to the enduring bonds of family, this hilarious and moving new play by Colman Domingo (author of Vineyard’s A Boy and His Soul and Tony Award nominee for his role in Vineyard’s production of The Scottsboro Boys) grapples unforgettably with aging parents, midlife crises, and the heart of an inner city neighborhood. It's directed by Tony Award winner Susan Stroman, who returns to The Vineyard after her ground-breaking work on The Scottsboro Boys.

Sixth Annual Fall Symposium & Luncheon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Sixth Annual
Fall Symposium & Luncheon

Sixth Annual Fall Symposium & Luncheon

November 9, 2015

 

The Pierre
New York, NY

 

Luncheon Host: Paula Zahn 


Margaret and Daniel Loeb received The Charles Evans Award at our Sixth Annual Fall Symposium & Luncheon “Hope on the Horizon” at The Pierre in New York City. Thanks to the generosity of our donors, the Symposium & Luncheon raised more than $1 million, the most in the event’s history. All proceeds support our mission to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer’s disease.  

Following the awards ceremony, Emmy Award-winning journalist Paula Zahn conducted a thought-provoking interview with Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the ADDF, and Richard Mohs, PhD, Retired Vice President for Neuroscience Early Clinical Development & Distinguished Research Fellow, Eli Lilly and Company. Dr. Fillit and Dr. Mohs discussed the enormous progress that has already been made and explained the potential of new treatments for Alzheimer’s currently in clinical trials.

The morning Symposium by Dr. Fillit, “Conquering Alzheimer’s Disease,” was opened by Ronald S. Lauder, who told the riveted audience: “Hope really is on the horizon. Thanks to the extraordinary efforts of the ADDF and the scientists it funds across the globe, we’re closer than ever to conquering this disease.” 


©Patrick McMullan
Photo - Sean Zanni/PMC

2015 TCS New York City Marathon | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

2015 TCS New York City Marathon

2015 TCS New York City Marathon

November 1, 2015

 


New York, NY

The Alzheimer's Drug Discovery Foundation is thrilled to be an official charity partner of the 2015 TCS New York City Marathon.

Our team of eight "Runners for Alzheimer’s Research" are passionate about finding a cure for Alzheimer’s disease. While more than 5.5 million Americans are currently living with Alzheimer’s (the third-leading cause of death in the United States) research for a cure remains underfunded.

By supporting our team, you will help us further our mission to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease.

DONATE
ADDF at the Society for Neuroscience Annual Meeting 2015 | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

ADDF to Exhibit at
The Society for Neuroscience Annual Meeting

ADDF at the Society for Neuroscience Annual Meeting 2015

October 17-21, 2015

 

Hyatt Regency Chicago
Chicago, IL

The ADDF team was at booth 2028 in 2015. They provided information about our upcoming conferences, grant opportunities, ADDF ACCESS program and much more at the Society for Neuroscience Annual Meeting!

16th International Conference on Alzheimer’s Drug Discovery | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

16th International Conference on Alzheimer’s Drug Discovery

16th International Conference on Alzheimer’s Drug Discovery

October 4-6, 2015

 

Hyatt Regency
Jersey City, NJ

This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top-level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunity for collaboration and partnering. For complete program and registration information, please visit our conference website.

Program Outline

Sunday, October 4, 2015
5:00–7:00 pm
On-Site Pre-Registration

Monday, October 5, 2015
8:00–9:20 am
Breakfast, Welcome & Plenary Lecture: Neuroinflammation: Mechanisms and Targets

9:30–12:30 pm
SESSION I: Apolipoproteins and Neuroinflammation

12:30–1:30 pm
Lunch, Poster and Exhibitor Session

1:35–5:10 pm
SESSION II: Neuroprotection, Mitochondrial Function and Synaptic Plasticity

5:20–7:00 pm
Networking Reception & Poster and Exhibitor Session

Tuesday, October 6, 2015
8:00–9:20 am
Breakfast, Welcome & Plenary Lecture: Progress and Future Directions in Tau Imaging

9:10 am–12:35 pm
SESSION III: Translatable Biomarkers to Accelerate Clinical Development

12:35–1:25 pm
Lunch, Poster and Exhibitor Session

1:25–4:20 pm
SESSION IV: TAU TDP-43, Progranulin and Protein Clearance

4:20–4:30 pm
Closing Remarks

Research Connecting Alzheimer’s and Mitochondrial Disease | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Hope Flies Health Series:
Research Connecting Alzheimer’s and Mitochondrial Disease

Research Connecting Alzheimer’s and Mitochondrial Disease

September 23, 2015

 


Webinar

Panelists:

  • Diana Shineman, Scientific Director of the Alzheimer’s Drug Discovery Foundation

  • Laura Stanley, Executive Director, Foundation for Mitochondrial Medicine

  • Cristy Balcells, RN, Executive Director, Mitoaction

  • Moderator: Darria Gillespie, MD MBA FACEP, SVP Clinical Strategy, Shareware

Learn more about the scientific connection and interest Alzheimer’s researchers have in mitochondria in this webinar. Hear about a specific research project the FMM and ADDF co-funded exploring this link. Understand similar challenges mitochondrial patients and Alzheimer’s patients face and how the day-to-day can be managed while treatment options are still being researched in the laboratory.

Q&A will follow with the panelists. Register online.

AspenBrainLab | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

AspenBrainLab

AspenBrainLab

July 25, 2015

 

Paepcke Auditorium
Aspen, Colorado

The third annual AspenBrainLab presents a provocative program of 12 brilliant short talks and meditations, all about the brain, that reframe what we know and what we think. Highlights include Dr. Howard Fillit on "Cracking the Alzheimer's Code," Walter Isaacson on "The Innovative Mind," William Moyers discussing his addiction and recovery, and six Tibetan Monks leading a chanting meditation.

Visit aspenbrainlab.com for the complete agenda and to register.

Learning from Cancer to Advance Neurodegeneration Drug Discovery and Development | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Learning from Cancer to Advance Neurodegeneration Drug Discovery and Development

Learning from Cancer to Advance Neurodegeneration Drug Discovery and Development

June 11, 2015

 

The New York Academy of Sciences
New York, NY

Does having cancer decrease your risk of developing neurodegenerative diseases? Why do many cancer drug targets overlap with targets for neurodegeneration? This interdisciplinary meeting seeks to answer these questions and help attendees learn from the mechanistic insight and years of research on cancer biology to advance new therapeutic development for neurodegenerative diseases. Speakers will address how their research relates to both cancer and neurodegeneration and what we can learn about cell biology and function from these seemingly disparate diseases. Talks will also discuss cancer drug repurposing opportunities for Alzheimer’s and related dementias.

*Reception to follow.

For more information on the program, please visit the New York Academy of Sciences website.

Art Tour for Alzheimer’s | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Art Tour for Alzheimer’s

Art Tour for Alzheimer’s

May 19, 2015

5:30 – 7:00 pm

Ticket Price: $150

 


New York, NY

Join the Alzheimer’s Drug Discovery Foundation for cocktails and an exclusive guided tour of contemporary art galleries in New York’s Chelsea neighborhood. Hosted by ArtMuse founder Natasha Schlesinger, the Art Tour for Alzheimer’s is a unique opportunity to network with professionals passionate about Alzheimer’s while exploring the New York art scene with an award-winning art historian by your side.

RSVP to Jessica Cavanaugh at jcavanaugh@alzdiscovery.org or 212.901.8011 by Friday, May 1st. Spaces are limited.

Ninth Annual Connoisseur’s Dinner | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Ninth Annual
Connoisseur's Dinner

Ninth Annual Connoisseur’s Dinner

April 27, 2015

 

Sotheby's
New York, NY

On Monday, April 27, 2015, American theatre director, choreographer, film director and performer Susan Stroman hosted the Alzheimer’s Drug Discovery Foundation’s (ADDF) Ninth Annual Connoisseur’s Dinner at Sotheby’s in New York City.

With an audience of more than 230, Stroman spoke poignantly about the experience of losing her partner, director Steven Weisberg, to early-onset Alzheimer’s. “It’s devastating to watch someone disappear in front of you,” she said. “The ADDF gives us hope for a treatment one day.”

Co-chaired by Leonard A. Lauder of the Estée Lauder cosmetics family, the black-tie event featured fine wine, food and art. Also in attendance were Barbara and Donald Tober, Rose Marie Bravo, Paula Zahn and Meryl Comer.

Jamie Niven, Chairman, Sotheby’s Americas, hosted the evening’s lively “Fund a Scientist” auction, which gave guests the opportunity to support the science of three renowned Alzheimer’s researchers: Roberta Diaz Brinton, PhD, of the University of Southern California, and Joseph Foss, MD, and Mohamed Naguib, MD, of the Cleveland Clinic Foundation. The auction raised more than $1 million.

Later in the evening, Leonard A. Lauder presented the ADDF’s Founding Executive Director and Chief Science Officer, Howard Fillit, MD, with the Chairman’s Award for Lifetime Achievement. Dr. Fillit, a geriatrician, neuroscientist and leading expert in Alzheimer’s disease, was recognized for leading a life of compassion, innovation and leadership in Alzheimer’s disease.

Said Dr. Fillit, “Our ambition at ADDF is to create a world of older people who, despite some arthritis, heart disease, and even surviving a cancer, have the mental vitality to continue to contribute productively to society, to give back with wisdom because of decades of experience, and provide a legacy of love to families and friends.”


​VIEW PHOTOS FROM THE EVENT:

 

©Patrick McMullan

Fifth Annual Great Ladies Luncheon & Fashion Show | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation

Fifth Annual
Great Ladies Luncheon & Fashion Show

Fifth Annual Great Ladies Luncheon & Fashion Show

April 15, 2015

 

The Ritz-Carlton
Washington, DC

On Wednesday, April 15, 2015, renowned journalist and NPR host Diane Rehm welcomed guests to the Alzheimer’s Drug Discovery Foundation’s (ADDF) Fifth Annual Great Ladies Luncheon & Fashion Show at The Ritz-Carlton in Washington, DC.

Rehm, who has long used her public platform to raise awareness for Alzheimer’s disease, spoke eloquently about the need to increase support for drug discovery for Alzheimer’s. She also expressed hope for the future, noting that “there are hundreds of new, potentially disease-modifying drugs in the pipeline.”

The Great Ladies Luncheon & Fashion Show is the brainchild of Elise Lefkowitz, a well-known Washingtonian who lost her mother, Estelle Gelman, to Alzheimer’s disease. Elise and her husband Marc generously underwrite the fashion extravaganza on an annual basis.

In its fifth year, the Neiman Marcus-sponsored event featured a runway show with designs from Akris’s Fall/Winter 2015/16 Collection. The Swiss-luxury brand is immensely popular among the DC social set.

This year’s Luncheon & Fashion Show honored Emmy-Award winning journalist and author Meryl Comer. Comer’s New York Time’s bestseller, “Slow Dancing with a Stranger,” details her painful experience caring for her husband, who suffers from early-onset Alzheimer’s disease. 

Accepting her award, Comer said, “I fight for everyone who is well. I fight for all women because I want better options for them. And I fight because I don’t want my great grandchildren asking how their grandparent could forget them.”

The day began with a science symposium from the ADDF’s Founding Executive Director and Chief Science Officer, Howard Fillit, MD, who was joined by Roberta Diaz Brinton, PhD, of the University of Southern California. Entitled “Women and Alzheimer’s Disease,” the presentation explored the reasons women are more likely to develop Alzheimer’s disease.

With funding from the ADDF, Dr. Brinton is developing a drug, Allopregnanolone, which can reverse memory deficits in mice and restore normal cognitive function. During her presentation, Dr. Brinton noted that “it’s not the years women age [that increases their risk for Alzheimer’s] it’s the way that they age.”

The Great Ladies Luncheon & Fashion Show raised more than $229,000 to support Alzheimer's drug research.

Guests included:  Diane Rehm (Host and Executive Producer, “The Diane Rehm Show”), Meryl Comer (Emmy-Award Winning Journalist, Author of “Slowing Dancing with a Stranger,” and Alzheimer’s advocate), Elise Lefkowitz (Washington DC philanthropist), Roberta Diaz Brinton, PhD (Vanderveen Chair in Therapeutic Discovery and Development at the University of Southern California), Howard Fillit, MD (Founding Executive Director and Chief Science Officer, Alzheimer’s Drug Discovery Foundation), Ann B. Friedman (Director of Conservation International and wife of Thomas L. Friedman), Trish and George Vradenburg (Co-founders, UsAgainstAlzheimer’s and Washington DC philanthropists.)

WATCH:
Women and Alzheimer’s Disease Presentation

EVENT SPONSORS


  • Estee Lauder Companies
  • Neiman Marcus
  • Kris
Comparative Effectiveness Advisory Panel | Alzheimer’s Drug Discovery Foundation | Alzheimer's Drug Discovery Foundation